Alberto Barengo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Alberto Barengo has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Claudio Cavallini
Struttura Complessa di Cardiologia, Hospital S. Maria della Misericordia, 06129 Perugia, Italy
1 shared publication - Fabio Angeli
Department of Medicine and Technological Innovation (DiMIT), University of Insubria, Varese, Italy; Department of Medicine and Cardiopulmonary Rehabilitation, Istituti Clinici Scientifici Maugeri, IRCCS Tradate, Italy
1 shared publication - Francesco Notaristefano
Department of Cardiac Pacing and Electrophysiology, Hopital Cardiologique du Haut-Leveque, Bordeaux University Hospital (CHU) , 1 Avenue de Magellan, Pessac Cedex 33604
1 shared publication - Gianluca Zingarini
Struttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy
1 shared publication - Giuseppe Bagliani
Struttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy
1 shared publication - Giuseppe Giuffrè
Struttura Complessa di Cardiologia, Hospital of Perugia, 06129 Perugia, Italy
1 shared publication
Latest Publications
- Open Access
- 20 October 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (10) , 362
Inadvertent Lead Malposition in the Left Heart during Implantation of Cardiac Electric Devices: A Systematic Review
Background. The inadvertent lead malposition in the left heart (ILMLH) is an under-recognized event, which may complicate the implantation of cardiac electronic devices (CIEDs). Methods. We investigated the clinical conditions associated with ILMLH and the treatment strategies in these patients. We made a systematic review of the literature and identified 132 studies which reported 157 patients with ILMLH. Results. The mean age of patients was 68 years, and 83 were women. ILMLH was diagnosed, on average, 365 days after CIEDs implantation. Coexisting conditions were patent foramen ovale in 29% of patients, arterial puncture in 24%, perforation of the interatrial septum in 20%, atrial septal defect in 16% and perforation of the interventricular septum in 4%. At the time of diagnosis of ILMLH, 46% of patients were asymptomatic, 31% had acute TIA or stroke and 15% had overt heart failure. Overall, 14% of patients were receiving anticoagulants at the time of diagnosis of ILMLH. After diagnosis of ILMLH, percutaneous or surgical lead extraction was carried out in 93 patients (59%), whereas 43 (27%) received anticoagulation. During a mean 9-month follow-up after diagnosis of ILMLH, four patients experienced TIA or stroke (three on oral anticoagulant therapy and one after percutaneous lead extraction). Conclusion. ILMLH is a rare complication, which is usually diagnosed about one year after implantation of CIEDs. An early diagnosis of ILMLH is important. Lead extraction is a safe and effective alternative to anticoagulants.
- 20 October 2022
- Published by MDPI AG in Journal of Cardiovascular Development and Disease
- Vol. 9 (10) , 362
Open AccessInadvertent Lead Malposition in the Left Heart during Implantation of Cardiac Electric Devices: A Systematic Review
Background. The inadvertent lead malposition in the left heart (ILMLH) is an under-recognized event, which may complicate the implantation of cardiac electronic devices (CIEDs). Methods. We investigated the clinical conditions associated with ILMLH and the treatment strategies in these patients. We made a systematic review of the literature and identified 132 studies which reported 157 patients with ILMLH. Results. The mean age of patients was 68 years, and 83 were women. ILMLH was diagnosed, on average, 365 days after CIEDs implantation. Coexisting conditions were patent foramen ovale in 29% of patients, arterial puncture in 24%, perforation of the interatrial septum in 20%, atrial septal defect in 16% and perforation of the interventricular septum in 4%. At the time of diagnosis of ILMLH, 46% of patients were asymptomatic, 31% had acute TIA or stroke and 15% had overt heart failure. Overall, 14% of patients were receiving anticoagulants at the time of diagnosis of ILMLH. After diagnosis of ILMLH, percutaneous or surgical lead extraction was carried out in 93 patients (59%), whereas 43 (27%) received anticoagulation. During a mean 9-month follow-up after diagnosis of ILMLH, four patients experienced TIA or stroke (three on oral anticoagulant therapy and one after percutaneous lead extraction). Conclusion. ILMLH is a rare complication, which is usually diagnosed about one year after implantation of CIEDs. An early diagnosis of ILMLH is important. Lead extraction is a safe and effective alternative to anticoagulants.